HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefan Joos Selected Research

Pyridinolcarbamate (P23)

4/2009Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stefan Joos Research Topics

Disease

19Neoplasms (Cancer)
09/2015 - 07/2003
7Squamous Cell Carcinoma of Head and Neck
08/2010 - 09/2003
4Glioma (Gliomas)
02/2010 - 10/2005
4Medulloblastoma
04/2009 - 05/2004
3Liposarcoma
09/2006 - 05/2002
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
04/2009 - 12/2005
2Carcinogenesis
02/2006 - 03/2004
2Hodgkin Disease (Hodgkin's Disease)
12/2005 - 05/2003
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
09/2015
1Hepatocellular Carcinoma (Hepatoma)
10/2009
1Brain Neoplasms (Brain Tumor)
12/2008
1Glioblastoma (Glioblastoma Multiforme)
12/2008
1Lymphatic Metastasis
05/2008
1Astrocytoma (Pilocytic Astrocytoma)
05/2008
1Microsatellite Instability
05/2007
1Disease Progression
02/2007
1Mouth Neoplasms (Oral Cancer)
02/2007
1Thymoma (Thymic Carcinoma)
11/2006
1Neurofibrosarcoma (MPNST)
09/2006
1Sarcoma (Soft Tissue Sarcoma)
09/2006
1Malignant Fibrous Histiocytoma
09/2006
1Basal Cell Carcinoma (Rodent Ulcer)
05/2006
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
12/2005
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2003
1Breast Neoplasms (Breast Cancer)
07/2003
1Sclerosis
02/2002
1Lymphoma (Lymphomas)
02/2002

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
09/2015 - 07/2003
4DNA (Deoxyribonucleic Acid)IBA
04/2009 - 12/2005
3Biological ProductsIBA
05/2008 - 05/2002
2Oncogene Proteins (Oncogene Protein)IBA
10/2009 - 09/2003
2Phosphotransferases (Kinase)IBA
12/2008 - 05/2008
2Messenger RNA (mRNA)IBA
05/2008 - 02/2006
2A-Form DNA (A-DNA)IBA
01/2007 - 09/2006
2Cyclin D1IBA
02/2006 - 05/2004
1Apoptosomes (Apoptosome)IBA
09/2015
1Mitogen-Activated Protein Kinase PhosphatasesIBA
02/2010
1Mitogen-Activated Protein KinasesIBA
02/2010
1SOXB1 Transcription FactorsIBA
01/2010
1ElementsIBA
10/2009
1Carrier Proteins (Binding Protein)IBA
10/2009
1Pyridinolcarbamate (P23)IBA
04/2009
1Biomarkers (Surrogate Marker)IBA
04/2009
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
12/2008
1Troglitazone (Rezulin)FDA Link
12/2008
1Pharmaceutical PreparationsIBA
12/2008
1LigandsIBA
12/2008
1PPAR gammaIBA
12/2008
1MitogensIBA
05/2008
1OligonucleotidesIBA
05/2008
1Small Interfering RNA (siRNA)IBA
05/2008
1Transforming Growth Factor beta (TGF-beta)IBA
05/2008
1Telomerase (Telomerase Reverse Transcriptase)IBA
05/2007
1SurvivinIBA
02/2007
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
01/2007
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2006
1NF-kappa B (NF-kB)IBA
12/2005
1Transcription Factors (Transcription Factor)IBA
12/2005
1Cyclin-Dependent Kinase Inhibitor p16IBA
04/2005
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
04/2005
1StathminIBA
05/2004
1Codon (Codons)IBA
10/2003
1Apoptosis Regulatory ProteinsIBA
07/2003
1HMGB1 Protein (HMG1)IBA
07/2003
1Proto-Oncogene Proteins c-relIBA
05/2003
1Complementary DNA (cDNA)IBA
06/2002
1RNA (Ribonucleic Acid)IBA
06/2002
1LR 16IBA
02/2002

Therapy/Procedure

8Therapeutics
09/2015 - 07/2003
1Heterologous Transplantation (Xenotransplantation)
10/2009
1Radiotherapy
02/2007
1Drug Therapy (Chemotherapy)
05/2004